نتایج جستجو برای: peginterferon alfa

تعداد نتایج: 19203  

Journal: :International journal of technology assessment in health care 2012
Debbie Hartwell Jeremy Jones Louise Baxter Jonathan Shepherd

BACKGROUND Peginterferon alfa and ribavirin combination therapy is an effective treatment for many patients with chronic hepatitis C virus (HCV). Reducing the length of treatment may be advantageous. We performed a systematic review and economic evaluation to assess shorter treatment duration of this regimen. METHODS We searched fourteen bibliographic databases (including The Cochrane Library...

Journal: :Journal of managed care pharmacy : JMCP 2009
Eduardo L Marino Luis Alvarez-Rubio Silvia Miro Pilar Modamio Fernando Banos Cecilia F Lastra Aintzane Alberdi-Leniz

Chronic hepatitis C infection affects nearly 300 million people worldwide. It is one of the main causes of chronic liver disease and the most common indication for liver transplantation.1-5 There are 6 major strains or genotypes of hepatitis C virus (HCV). These genotypes have different geographic distributions, with the type 1 genotype (HCV-1) most common in the United States (accounting for a...

Journal: :Brazilian Journal of Pharmaceutical Sciences 2023

The purpose of the present study was to develop stable lyophilized formulation peginterferon alfa-2b which is acquiescent short lyophilization process. evaluates effect buffering components and cryoprotectant(s) on depegylation in combination with Finally, a process identified can produce pharmaceutical form without any during long-term storage. Formulations were analyzed mainly for by HP-size ...

2013
Alireza Mehrazmay Seyed Moayed Alavian Maziar Moradi-Lakeh Mahdi Mokhtari Payam Amir Hashemi-Meshkini Bita Behnava Seyyed Mohammad Miri Pegah Karimi Elizee Seyed Vahid Tabatabaee Maryam Keshvari Kamran Bagheri Lankarani

BACKGROUND The prevalence of hepatitis C in Iran is 1% and 18% in general population and thalassemia patients respectively. The cost effectiveness analysis of adding Ribavirin to Peginterferon alfa-2a (PEG IFN alfa-2a) as a combination treatment strategy of chronic hepatitis C in thalassemia patients in comparison with monotherapy could help clinicians and policy makers to provide the best trea...

Journal: :Journal of managed care pharmacy : JMCP 2005
Daniel C Malone Tram T Tran F Fred Poordad

OBJECTIVE Combination therapy with pegylated interferon (Peg) and ribavirin (RBV) is the standard of care for the treatment of chronic hepatitis C virus (HCV) infection. This analysis compares the cost efficacy of treatment with pegylated interferon alfa-2b plus ribavirin (Peg-2b plus RBV) with pegylated interferon alfa-2a plus ribavirin (Peg-2a plus RBV) in hypothetical cohorts of 100 chronic ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید